UCB Dedicates Future Site of US Biologics Manufacturing Campus in Georgia

URLhttps://www.contractpharma.com/breaking-news/ucb-d
SourceContract Pharma
Date Published10/12/2026

Additional Reshoring Information:

Company/Division name UCB
Parent companyUnion Chimique Belge
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):330
Year reshoring announced:2026
Domestically, the work will be done:In-house
Capital investment ($):2000
Country(ies) from which reshored:Belgium
City reshored to:Gwinnett County
State(s) reshored to:GA
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredpharmaceuticals
What domestic positive factors made reshoring more attractive?Impact on domestic economy, Infrastructure, Skilled workforce availability/training
Find Reshoring Articles